Collegium cuts 2026 revenue guidance on weaker Nucynta generic pricingAug 6M&ACollegium Pharmaceutical, Inctapentadol
Zevra reports Q2 2026 results as MIPLYFFA revenue grows and EU review continuesAug 5Quarterly updatearimoclomolZevra Therapeutics, Inc.
Sign inSign in